IL187142A0 - Combination therapy with sulodexide and a blood pressure reducing agent in the treatment of diabetic nephropathy - Google Patents

Combination therapy with sulodexide and a blood pressure reducing agent in the treatment of diabetic nephropathy

Info

Publication number
IL187142A0
IL187142A0 IL187142A IL18714207A IL187142A0 IL 187142 A0 IL187142 A0 IL 187142A0 IL 187142 A IL187142 A IL 187142A IL 18714207 A IL18714207 A IL 18714207A IL 187142 A0 IL187142 A0 IL 187142A0
Authority
IL
Israel
Prior art keywords
sulodexide
treatment
reducing agent
blood pressure
pressure reducing
Prior art date
Application number
IL187142A
Other languages
English (en)
Original Assignee
Keryx Biopharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Keryx Biopharmaceuticals Inc filed Critical Keryx Biopharmaceuticals Inc
Publication of IL187142A0 publication Critical patent/IL187142A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
IL187142A 2005-05-05 2007-11-04 Combination therapy with sulodexide and a blood pressure reducing agent in the treatment of diabetic nephropathy IL187142A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67909605P 2005-05-05 2005-05-05
US73697305P 2005-11-14 2005-11-14
PCT/US2006/017403 WO2006121853A1 (en) 2005-05-05 2006-05-05 Combination therapy with sulodexide and a blood pressure reducing agent in the treatment of diabetic nephropathy

Publications (1)

Publication Number Publication Date
IL187142A0 true IL187142A0 (en) 2008-06-05

Family

ID=37396874

Family Applications (1)

Application Number Title Priority Date Filing Date
IL187142A IL187142A0 (en) 2005-05-05 2007-11-04 Combination therapy with sulodexide and a blood pressure reducing agent in the treatment of diabetic nephropathy

Country Status (6)

Country Link
EP (1) EP1883412A4 (de)
JP (1) JP2008540448A (de)
AU (1) AU2006244446A1 (de)
CA (1) CA2606880A1 (de)
IL (1) IL187142A0 (de)
WO (1) WO2006121853A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2008008213A (es) 2005-12-22 2008-09-03 Neurochem Int Ltd Tratamiento de trastornos renales, nefropatia diabetica y dislipidemias.
CN101632686A (zh) * 2008-04-04 2010-01-27 马斯特里赫特大学 糖胺聚糖用于修复糖萼的用途
CN104017102B (zh) * 2014-06-19 2016-02-24 深圳市海普瑞药业股份有限公司 乙醇沉淀法从肝素副产物制备舒洛地特原料的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1270846B (it) * 1993-05-10 1997-05-13 Alfa Wassermann Spa Uso di sulodexide e delle specialita' medicinali che lo contengono nel trattamento della nefropatia diabetica.
IT1292426B1 (it) * 1997-06-27 1999-02-08 Nicox Sa Sali nitrati di ace-inibitori
US7259152B2 (en) * 2000-06-07 2007-08-21 Alfa Wasserman, Inc. Methods and compositions using sulodexide for the treatment of diabetic nephropathy

Also Published As

Publication number Publication date
CA2606880A1 (en) 2006-11-16
EP1883412A1 (de) 2008-02-06
AU2006244446A1 (en) 2006-11-16
WO2006121853A1 (en) 2006-11-16
JP2008540448A (ja) 2008-11-20
EP1883412A4 (de) 2008-09-03

Similar Documents

Publication Publication Date Title
IL236831A0 (en) Expression of micro rna in peripheral narrow blood vessels in the human body, and their uses
EP2043705A4 (de) System und verfahren zur verwendung eines wirkstoffs in kombination mit einer gewebebehandlung durch subatmosphärischen druck
IL246402A (en) A therapeutic component for treating obesity, diabetes and impaired glucose tolerance
HUE064811T2 (hu) Extendin diabétesz kezelésében és testtömeg csökkentésében történõ alkalmazásra
KZ24152B (en) Method of photosensitizer activation, treatment method with application of activated photosensitizer and photosensitizer application to prepare medicine
EP1799263A4 (de) Reduzierung von er-stress bei der behandlung von adipositas und diabetes
IL207894A (en) Medical combination for use in the treatment of cancer including trastuzumab – mcc – dmi and chemotherapeutic agent
IL186592A0 (en) Treatment and diagnostic catheters with hydrogel electrodes
HK1158705A1 (zh) 微泡在醫學疾病和病況的診斷、預後以及治療中的用途
GB0523576D0 (en) Drug composition and its use in therapy
EP2061531A4 (de) Intravaskuläre blutpumpe und katheter
PL1912650T3 (pl) Zastosowanie flibanseryny w leczeniu otyłości
EP2059183A4 (de) In dentale und medizinische behandlungen eingebundene energetisch aktivierte biomedizinische nanotherapeutika sowie verfahren
EP2046973A4 (de) Identifikation, beurteilung und behandlung von krebstherapiepatienten
GB0700436D0 (en) Impulse therapy for enhanced blood circulation in the body
IL190206A0 (en) Method for lowering blood pressure in pre-hypertensive individuals and/or individuals with metabolic syndrome
IL183056A0 (en) Use of ranolazine in combination with at least one remodeling agent for revering ieft ventricular remodeling in the treatment of heart failure
HK1168283A1 (zh) 類的試劑在治療抗胰島素和相關疾病的用途
EP2086506A4 (de) Zubereitung von schwermetallhaltigen nano-liposomen und ihre verwendungen in der medizinischen therapie
IL201426A0 (en) Drug combination and its use in the treatment of muscle loss
EP2046313A4 (de) Verwendung von naphthochinonen bei der behandlung und kontrolle von diabetes, insulinresistenz und hyperglykämie
IL187142A0 (en) Combination therapy with sulodexide and a blood pressure reducing agent in the treatment of diabetic nephropathy
GB0821839D0 (en) The use of metformin and compounds containing metformin in the treatment of diseases or conditions in patients with raised serum amyloid A
GB0700911D0 (en) Treatment of inflammation and the complement and kinin cascades in a patient, particularly in chronic ulcerous skin lesions
PT2160213E (pt) Conjunto para tratamento extracorporal de um fluido biológico de um paciente, e unidade dotada do referido conjunto